← All Sponsors
SPONSOR

4TEEN4 Pharmaceuticals GmbH

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Shock, Cardiogenic
NCT06832722 Phase 1, Phase 2
Recruiting

Procizumab (PCZ; AK1967) in Critical Cardiovascular Care

Shock, Cardiogenic
Belgium, Czechia, France View Trial →